Trial Profile
A Phase I, Single Blind, Randomized, Placebo Controlled, Drug Interaction Study of Intravenous (IV) Valortim and Intravenous (IV) Ciprofloxacin in Healthy, Normal Subjects
Status:
Suspended
Phase of Trial:
Phase I
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs MDX 1303 (Primary) ; Ciprofloxacin
- Indications Anthrax; Bacterial infections
- Focus Adverse reactions
- Sponsors PharmAthene
- 09 Aug 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 02 Sep 2009 New trial record